lamotrigine has been researched along with indantadol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassani, F; Bergamaschi, M; Bregola, G; Pietra, C; Rondelli, I; Simonato, M; Villetti, G | 1 |
| Bergamaschi, M; Buzzi, A; Pietra, C; Simonato, M; Villetti, G; Zucchini, S | 1 |
2 other study(ies) available for lamotrigine and indantadol
| Article | Year |
|---|---|
Preclinical evaluation of CHF3381 as a novel antiepileptic agent.
Topics: Animals; Anticonvulsants; Dizocilpine Maleate; Drug Evaluation, Preclinical; Epilepsy; Excitatory Amino Acid Antagonists; Glycine; Indans; Kindling, Neurologic; Lamotrigine; Male; Mice; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Triazines | 2001 |
Neuroprotective activity of CHF3381, a putative N-methyl-D-aspartate receptor antagonist.
Topics: Animals; Anticonvulsants; Cell Death; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glycine; Hippocampus; Histological Techniques; Indans; Kainic Acid; Lamotrigine; Male; Mice; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Seizures; Triazines | 2002 |